WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, March 30, 2005, 25(13):3270-3279; doi:10.1523/JNEUROSCI.5033-04.2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (49)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonanno, G.
Right arrow Articles by Popoli, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonanno, G.
Right arrow Articles by Popoli, M.

 Previous Article  |  Next Article 

Cellular/Molecular
Chronic Antidepressants Reduce Depolarization-Evoked Glutamate Release and Protein Interactions Favoring Formation of SNARE Complex in Hippocampus

Giambattista Bonanno,1 Roberto Giambelli,2 * Luca Raiteri,1 * Ettore Tiraboschi,3 Simona Zappettini,1 Laura Musazzi,3 Maurizio Raiteri,1 Giorgio Racagni,2,3 and Maurizio Popoli3

1Section of Pharmacology and Toxicology, Department of Experimental Medicine, and Center of Excellence for Biomedical Research, University of Genoa, 16148 Genoa, Italy, 2Genetics Unit, Istituto di Ricovero e Cura a Carattere Scientifico, Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy, and 3Center of Neuropharmacology, Department of Pharmacological Sciences, and Center of Excellence on Neurodegenerative Diseases, University of Milan, 20133 Milan, Italy

Glutamate neurotransmission was recently implicated in the action of stress and in antidepressant mechanisms. We report that chronic (not acute) treatment with three antidepressants with different primary mechanisms (fluoxetine, reboxetine, and desipramine) markedly reduced depolarization-evoked release of glutamate, stimulated by 15 or 25 mM KCl, but not release of GABA. Endogenous glutamate and GABA release was measured in superfused synaptosomes, freshly prepared from hippocampus of drug-treated rats. Interestingly, treatment with the three drugs only barely changed the release of glutamate (and of GABA) induced by ionomycin. In synaptic membranes of chronically treated rats we found a marked reduction in the protein-protein interaction between syntaxin 1 and Thr286-phosphorylated {alpha}CaM kinase II ({alpha}-calcium/calmodulin-dependent protein kinase II) (an interaction previously proposed to promote neurotransmitter release) and a marked increase in the interaction between syntaxin 1 and Munc-18 (an interaction proposed to reduce neurotransmitter release). Furthermore, we found a selective reduction in the expression level of the three proteins forming the core SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complex. These findings suggest that antidepressants work by stabilizing glutamate neurotransmission in the hippocampus and that they may represent a useful tool for the study of relationship between functional and molecular processes in nerve terminals.

Key words: release; glutamate; GABA; antidepressant; CaMKII; SNARE protein; neuroplasticity


Received Dec 10, 2004; revised February 2, 2005; accepted February 4, 2005.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
V. Bianchi, P. Farisello, P. Baldelli, V. Meskenaite, M. Milanese, M. Vecellio, S. Muhlemann, H. P. Lipp, G. Bonanno, F. Benfenati, et al.
Cognitive impairment in Gdi1-deficient mice is associated with altered synaptic vesicle pools and short-term synaptic plasticity, and can be corrected by appropriate learning training
Hum. Mol. Genet., January 1, 2009; 18(1): 105 - 117.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Chourbaji, M. A. Vogt, F. Fumagalli, R. Sohr, A. Frasca, C. Brandwein, H. Hortnagl, M. A. Riva, R. Sprengel, and P. Gass
AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression
FASEB J, September 1, 2008; 22(9): 3129 - 3134.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
M. Taylor, S. Murphy, S. Selvaraj, M. Wylezinkska, P. Jezzard, P. Cowen, and J. Evans
Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy
J Psychopharmacol, July 1, 2008; 22(5): 473 - 476.
[Abstract] [PDF]


Home page
Pharmacol. Rev.Home page
M. Raiteri
Functional pharmacology in human brain.
Pharmacol. Rev., June 1, 2006; 58(2): 162 - 193.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-